Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy
Abstract Over recent years, the development of new antibiotics has not kept pace with the rate at which bacteria develop resistance to these drugs. For this reason, many research groups have begun to design and study alternative therapeutics, including molecules to specifically inhibit the virulence...
Main Authors: | Eric Krueger, Angela C. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Journal of Biological Engineering |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13036-018-0138-z |
Similar Items
-
Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition
by: Osmel Fleitas Martínez, et al.
Published: (2019-04-01) -
Bacterial toxin effector membrane targeting: Outside in, then back again.
by: Brett eGeissler
Published: (2012-05-01) -
Applications of Catechins in the Treatment of Bacterial Infections
by: Meishan Wu, et al.
Published: (2021-05-01) -
Détection de la virulence bactérienne : caractérisation de la réponse immunitaire anti-virulence déclenchée par la toxine CNF1 d’Escherichia coli
by: Garcia, Elsa
Published: (2017) -
Development of Anti-Virulence Therapeutics against Mono-ADP-Ribosyltransferase Toxins
by: Miguel R. Lugo, et al.
Published: (2021-12-01)